1. Home
  2. SFL vs EVO Comparison

SFL vs EVO Comparison

Compare SFL & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SFL Corporation Ltd

SFL

SFL Corporation Ltd

HOLD

Current Price

$10.19

Market Cap

1.4B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.45

Market Cap

821.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFL
EVO
Founded
2003
1993
Country
Bermuda
Germany
Employees
N/A
4766
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
821.2M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
SFL
EVO
Price
$10.19
$2.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$7.00
AVG Volume (30 Days)
1.5M
115.5K
Earning Date
02-11-2026
05-05-2026
Dividend Yield
7.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.11
$7.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.73
$2.31
52 Week High
$11.28
$4.80

Technical Indicators

Market Signals
Indicator
SFL
EVO
Relative Strength Index (RSI) 49.94 29.39
Support Level $8.25 N/A
Resistance Level $11.28 $3.78
Average True Range (ATR) 0.26 0.09
MACD -0.17 -0.07
Stochastic Oscillator 26.46 11.40

Price Performance

Historical Comparison
SFL
EVO

About SFL SFL Corporation Ltd

SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: